SB 741 Oklahoma Senate · 2025 Regular Session

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

SB 741 allows Oklahoma pharmacists to test for and initiate drug therapy for minor, nonchronic health conditions (like colds or skin infections) under specific conditions. Pharmacists must follow a standing order from a physician or health department medical director and use only FDA-approved, CLIA-waived tests. The bill prohibits pharmacists from testing for or treating strep throat in children under six years old. This change directly affects pharmacists and patients seeking quick treatment for minor conditions without an immediate doctor’s visit, while expanding pharmacists’ clinical role within Oklahoma’s Pharmacy Act.
Bill status in committee 1 of 4 stages cleared
Introduction
Feb 2025
Committee Review
Floor Vote
Governor
Introduced Feb 3, 2025 Last action Mar 27, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Introduced Floor (Senate) · 4 edits
MODERATE
The bill was amended on the Senate floor to add a new definition for 'Dispenser' and 'Distribute' to clarify pharmacy practice terms, while retaining the core provisions allowing pharmacists to test for and initiate drug therapy for minor, nonchronic health conditions under a physician's standing order. The changes primarily involve technical updates to statutory definitions to ensure clarity and consistency in the Oklahoma Pharmacy Act.
Scope change
The bill's scope remains focused on expanding pharmacist authority to conduct drug therapy initiation for minor conditions, with no substantive changes to eligibility criteria or program requirements.
DEFINITION

Added new definitions for 'Distribute' and 'Dispenser' to clarify what constitutes distribution versus dispensing activities, and to exclude veterinary-only dispensers from the definition.

Revised the definition of 'Dispense' to remove redundant language and clarify that it includes selling, distributing, or supplying drugs.

Added a new definition for 'Doctor of Pharmacy' to establish interchangeability with 'pharmacist' and 'D.Ph.' throughout the statute.

TECHNICAL

Corrected formatting inconsistencies and updated page numbering from the original introduced version to reflect the Senate floor amendment status.

Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
8
Key actions
1
Committee
1
Mar 3, 2025
Upper · Passed
Reported Do Pass as amended Health and Human Services committee; CR filed
upper
Feb 3, 2025
Introduced
First Reading
upper
2 primary · 0 co-sponsors

Sponsors